SCHEMBL3884307

SCHEMBL3884307

CCNc1ccc2c(c1)oc1ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.56
NPC1 O15118 6/20 0.56
RAB9A P51151 6/20 0.56
ALDH1A1 P00352 5/20 0.55
KDM4E B2RXH2 5/20 0.55
HPGD P15428 4/20 0.55
HSD17B10 Q99714 4/20 0.55
POLB P06746 2/20 0.55
CASP1 P29466 1/20 0.55
RECQL P46063 1/20 0.55
CASP7 P55210 1/20 0.55
KMT2A Q03164 8/20 0.54
MEN1 O00255 7/20 0.54
GAA P10253 4/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
NPSR1 Q6W5P4 2/20 0.51
LMNA P02545 5/20 0.50
MAPT P10636 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885375 0.81 ALDH1A1 (0.54) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL20322817 0.80 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL3880546 0.80 RECQL (0.54) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL17283499 0.80 KMT2A (0.60) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL24742240 0.78 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL3875220 0.78 ALDH1A1 (0.56) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL8310085 0.77 RAB9A (0.56) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL20323086 0.77 RAB9A (0.54) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL6491493 0.76 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL3885260 0.75 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US claimed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US claimed
US-7491245-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2009-02-17 US disclosed
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US disclosed
US-7331997-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-02-19 US disclosed
EP-1735059-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-12-27 EP disclosed
WO-2005099656-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-10-27 WO disclosed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, TUBB6 SMN1; SMN2 4772/4885NPC1 4617/4885RAB9A 4019/4885
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof KRT18, CKMT1A; CKMT1B, TUBB6 SMN1; SMN2 4772/4885NPC1 4617/4885RAB9A 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.